Golden Retriever Lifetime Study
The Golden Retriever Lifetime Study is a groundbreaking effort to learn how to prevent cancer and other diseases in dogs. It is the largest and longest observational study ever undertaken to improve the health of dogs. The project will determine the genetic, nutritional and environmental risk factors for cancer and other diseases that affect dogs and is the largest and longest study of dogs ever undertaken. Structured as a ten year study with over 3,000 dogs this study will surely give us groundbreaking information and new data that will help us find a cure! Working with scientists, veterinarians and dog parents, Morris Animal Foundation is helping to prevent canine diseases so dogs can live longer, healthier lives. Please visit caninelifetimehealth.org to learn more.
Morris Animal Foundation is launching a new initiative to explore treatment for osteosarcoma, the most common bone tumor in dogs. The innovative project is called the Osteosarcoma Project and will fund the fight against metastatic osteosarcoma over five years, at the cost of $5 million. The first trial will evaluate Rapamycin, also known as Sirolimus, a promising cancer treatment drug that targets a protein that regulates cell growth. Rapamycin exhibits antibiotic, immunosuppressive and antifungal properties, and has been shown to prevent the growth of canine melanoma and the spread of osteosarcoma cells in vitro. These Foundation-funded trials will have the added benefit of helping to inform the clinical trials for kids with the same disease. If Rapamycin and other drugs are proven effective in these studies, they could be the next new treatments in the fight against metastatic osteosarcoma in dogs and maybe even people.
The MAF/BBFCR Fellowship in Small Companion Animal Nutrition is a two year award made to an institutional training program that will provide salary support for a post-DVM or post-PhD student pursuing post-doctoral research training in companion animal nutrition